According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports and stock price the company's current number of shares outstanding is 20,000,000. At the end of 2024 the company had 20,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.